Hims & Hers Health, Inc. Class A Common Stock (HIMS)

The market landscape is increasingly controlled by large firms that expand their reach by acquiring smaller competitors - a trend that the Trump administrati...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...

The past six months have been a windfall for Hims & Hers Health’s shareholders. The company’s stock price has jumped 40.2%, hitting $29.23 per share. This wa...

Hims & Hers Health shares fell 6.7% amid an FTC lawsuit over privacy and billing practices, a new securities class action, and a Q2 earnings miss that has weighed on the stock in 2026.

HIMS, ONDS, COIN, and SOFI show elevated short interest, but days-to-cover ratios, institutional ownership, and upcoming earnings reports suggest differing outlooks for short sellers.

The insider still retains significant holdings, valued at $8.5 million, despite the sale.

Hims & Hers surpassed the three million member milestone.

Hims & Hers Health is still growing rapidly, but whether that growth can translate into better economics could determine how much further the stock can climb.

MarketBeat analysts recap a mixed earnings week, covering AI infrastructure demand, retail's K-shaped consumer trends, Meta's $18 billion settlement, and stock picks across tech, biotech, and retail sectors.

The healthcare industry is ripe for disruption.

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Hims & Hers Health (NYSE:HIMS...

Check out the companies making headlines yesterday: Funko (NASDAQ:FNKO): Pop culture collectibles manufacturer Funko (NASDAQ:FNKO) rose by 4.9% on Monday aft...

What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 9.2% in the afternoon session after Bloomberg reported that Visa enrolled the...

Visa placed Hims & Hers Health into its Acquirer Monitoring Program after a billing dispute spike, adding penalty costs amid an FTC lawsuit and margin contraction.

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...

This filing notes that shares were withheld automatically to cover tax obligations from quarterly RSU vesting.

Soleil Boughton retains roughly 339,000 shares and additional derivative securities.

This tax-related withholding was tied to quarterly RSU vesting, not discretionary selling.

Tax withholding drove the disposal of 10,201 shares at $28.15 each, reducing this insider's direct holdings by 5%, though they're still up on a net basis given conversions.

This non-discretionary sale was tied to RSU tax withholding; the insider retains 65,734 direct shares and 428,000 derivative securities, per the filing.

The disposition comes as HIMS stock has declined 38% over the past 12 months.

This non-discretionary tax withholding reduced the CTO of Hims' direct holdings, though he retains roughly 194,000 shares and roughly 2 million derivative securities subject to multi-year vesting.

Stock-based compensation vesting triggered mandatory tax withholding, but Dudum retains about 9.7 million shares worth $272 million.

Subscriber growth accelerated as revenue surged 38% and international expansion took off.

Hims & Hers Health’s second quarter results were driven by strong subscriber growth and a ramp-up in its branded weight loss offerings, yet the market reacte...